Cite

HARVARD Citation

    Chanut, M. et al. (2022). Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura. Platelets. pp. 652-653. [Online]. 
  
Back to record